Loading…

Therapy Targeting Stem Cell in Patients with Decompensated Cirrhosis of Liver in a Tertiary Treatment Care Center of Bangladesh

Decompensated cirrhosis is associated with significantly high mortality resulting from hepatic failure, and liver transplantation seems to be the only viable indication for its management. The objective of this study is to assess if granulocyte colony-stimulating factor (G-CSF), a stimulatory of ste...

Full description

Saved in:
Bibliographic Details
Published in:Euroasian journal of hepato-gastroenterology 2017-06, Vol.7 (1), p.113-115
Main Authors: Al Mahtab, Mamun, Mn Alam, Sheikh, L Moben, Ahmed, Raihan, Ruksana, A Alam, Mohammad, A Rahim, Mohammad, H Uddin, Mohammad, Fazle Akbar, Sheikh Mohammad
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1230-30853c523ef780b8f37b3deaf2f6cc977609dca2f0300a1c9481b643cddee9cf3
cites cdi_FETCH-LOGICAL-c1230-30853c523ef780b8f37b3deaf2f6cc977609dca2f0300a1c9481b643cddee9cf3
container_end_page 115
container_issue 1
container_start_page 113
container_title Euroasian journal of hepato-gastroenterology
container_volume 7
creator Al Mahtab, Mamun
Mn Alam, Sheikh
L Moben, Ahmed
Raihan, Ruksana
A Alam, Mohammad
A Rahim, Mohammad
H Uddin, Mohammad
Fazle Akbar, Sheikh Mohammad
description Decompensated cirrhosis is associated with significantly high mortality resulting from hepatic failure, and liver transplantation seems to be the only viable indication for its management. The objective of this study is to assess if granulocyte colony-stimulating factor (G-CSF), a stimulatory of stem cell may be of any benefit for patients with decompensated cirrhosis of liver. Seventeen consecutive patients with decompensated cirrhosis of liver were recruited in this prospective study. They received injection of G-CSF (30 IU) over a period of 6 weeks (12 injections) in addition to standard of care. Patients were followed up at the end of treatment and at 12 weeks of treatment. Treatment was well tolerated, and no significant adverse event was recorded in any patient. Fifteen out of 17 (88%) patients were alive at last follow-up. Although serum bilirubin, albumin, and prothrombin time improved in some patients, statistically significant improvement of Child-Pugh score could not be documented. The study establishes the safety of G-CSF therapy in patients with decompensated cirrhosis of liver. Besides, such therapy may also have survival benefit, although long-term follow-up is needed to assess its real utility in clinical perspectives. Al Mahtab M, Alam SMN, Moben AL, Raihan R, Alam MA, Rahim MA, Uddin MH, Akbar SMF. Therapy Targeting Stem Cell in Patients with Decompensated Cirrhosis of Liver in a Tertiary Treatment Care Center of Bangladesh. Euroasian J Hepato-Gastroenterol 2017;7(1):113-115.
doi_str_mv 10.5005/jp-journals-10018-1229
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_5005_jp_journals_10018_1229</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>29201790</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1230-30853c523ef780b8f37b3deaf2f6cc977609dca2f0300a1c9481b643cddee9cf3</originalsourceid><addsrcrecordid>eNo9kMtOwzAQRS0Eoqj0Fyr_QGBsN68lhKdUCSTCOnKcceOoech2Qaz4dVxKmc3MYs7VzCFkyeAqBoivuynqxp0d5NZFDIBlEeM8PyEXnAsWxYxnp8cZVumMLJzrIFSW5Iyl52TGcw4szeGCfJctWjl90VLaDXozbOibx54WuN1SM9BX6Q0O3tFP41t6h2rsJxyc9NjQwljbjs44Omq6Nh9o94SkJVpvpA2ZFqXvA04LaTFkDj7shOVbOWy2skHXXpIzHd7AxV-fk_eH-7J4itYvj8_FzTpSjAuIBGSxUDEXqNMM6kyLtBYNSs11olSepgnkjZJcgwCQTOWrjNXJSqimQcyVFnOSHHKVHZ2zqKvJmj4cWTGo9lKrbqqOUqtfqdVeagCXB3Da1T02_9hRofgBStp35Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Therapy Targeting Stem Cell in Patients with Decompensated Cirrhosis of Liver in a Tertiary Treatment Care Center of Bangladesh</title><source>PubMed Central</source><creator>Al Mahtab, Mamun ; Mn Alam, Sheikh ; L Moben, Ahmed ; Raihan, Ruksana ; A Alam, Mohammad ; A Rahim, Mohammad ; H Uddin, Mohammad ; Fazle Akbar, Sheikh Mohammad</creator><creatorcontrib>Al Mahtab, Mamun ; Mn Alam, Sheikh ; L Moben, Ahmed ; Raihan, Ruksana ; A Alam, Mohammad ; A Rahim, Mohammad ; H Uddin, Mohammad ; Fazle Akbar, Sheikh Mohammad</creatorcontrib><description>Decompensated cirrhosis is associated with significantly high mortality resulting from hepatic failure, and liver transplantation seems to be the only viable indication for its management. The objective of this study is to assess if granulocyte colony-stimulating factor (G-CSF), a stimulatory of stem cell may be of any benefit for patients with decompensated cirrhosis of liver. Seventeen consecutive patients with decompensated cirrhosis of liver were recruited in this prospective study. They received injection of G-CSF (30 IU) over a period of 6 weeks (12 injections) in addition to standard of care. Patients were followed up at the end of treatment and at 12 weeks of treatment. Treatment was well tolerated, and no significant adverse event was recorded in any patient. Fifteen out of 17 (88%) patients were alive at last follow-up. Although serum bilirubin, albumin, and prothrombin time improved in some patients, statistically significant improvement of Child-Pugh score could not be documented. The study establishes the safety of G-CSF therapy in patients with decompensated cirrhosis of liver. Besides, such therapy may also have survival benefit, although long-term follow-up is needed to assess its real utility in clinical perspectives. Al Mahtab M, Alam SMN, Moben AL, Raihan R, Alam MA, Rahim MA, Uddin MH, Akbar SMF. Therapy Targeting Stem Cell in Patients with Decompensated Cirrhosis of Liver in a Tertiary Treatment Care Center of Bangladesh. Euroasian J Hepato-Gastroenterol 2017;7(1):113-115.</description><identifier>ISSN: 2231-5047</identifier><identifier>EISSN: 2231-5128</identifier><identifier>DOI: 10.5005/jp-journals-10018-1229</identifier><identifier>PMID: 29201790</identifier><language>eng</language><publisher>India</publisher><ispartof>Euroasian journal of hepato-gastroenterology, 2017-06, Vol.7 (1), p.113-115</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1230-30853c523ef780b8f37b3deaf2f6cc977609dca2f0300a1c9481b643cddee9cf3</citedby><cites>FETCH-LOGICAL-c1230-30853c523ef780b8f37b3deaf2f6cc977609dca2f0300a1c9481b643cddee9cf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29201790$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Al Mahtab, Mamun</creatorcontrib><creatorcontrib>Mn Alam, Sheikh</creatorcontrib><creatorcontrib>L Moben, Ahmed</creatorcontrib><creatorcontrib>Raihan, Ruksana</creatorcontrib><creatorcontrib>A Alam, Mohammad</creatorcontrib><creatorcontrib>A Rahim, Mohammad</creatorcontrib><creatorcontrib>H Uddin, Mohammad</creatorcontrib><creatorcontrib>Fazle Akbar, Sheikh Mohammad</creatorcontrib><title>Therapy Targeting Stem Cell in Patients with Decompensated Cirrhosis of Liver in a Tertiary Treatment Care Center of Bangladesh</title><title>Euroasian journal of hepato-gastroenterology</title><addtitle>Euroasian J Hepatogastroenterol</addtitle><description>Decompensated cirrhosis is associated with significantly high mortality resulting from hepatic failure, and liver transplantation seems to be the only viable indication for its management. The objective of this study is to assess if granulocyte colony-stimulating factor (G-CSF), a stimulatory of stem cell may be of any benefit for patients with decompensated cirrhosis of liver. Seventeen consecutive patients with decompensated cirrhosis of liver were recruited in this prospective study. They received injection of G-CSF (30 IU) over a period of 6 weeks (12 injections) in addition to standard of care. Patients were followed up at the end of treatment and at 12 weeks of treatment. Treatment was well tolerated, and no significant adverse event was recorded in any patient. Fifteen out of 17 (88%) patients were alive at last follow-up. Although serum bilirubin, albumin, and prothrombin time improved in some patients, statistically significant improvement of Child-Pugh score could not be documented. The study establishes the safety of G-CSF therapy in patients with decompensated cirrhosis of liver. Besides, such therapy may also have survival benefit, although long-term follow-up is needed to assess its real utility in clinical perspectives. Al Mahtab M, Alam SMN, Moben AL, Raihan R, Alam MA, Rahim MA, Uddin MH, Akbar SMF. Therapy Targeting Stem Cell in Patients with Decompensated Cirrhosis of Liver in a Tertiary Treatment Care Center of Bangladesh. Euroasian J Hepato-Gastroenterol 2017;7(1):113-115.</description><issn>2231-5047</issn><issn>2231-5128</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNo9kMtOwzAQRS0Eoqj0Fyr_QGBsN68lhKdUCSTCOnKcceOoech2Qaz4dVxKmc3MYs7VzCFkyeAqBoivuynqxp0d5NZFDIBlEeM8PyEXnAsWxYxnp8cZVumMLJzrIFSW5Iyl52TGcw4szeGCfJctWjl90VLaDXozbOibx54WuN1SM9BX6Q0O3tFP41t6h2rsJxyc9NjQwljbjs44Omq6Nh9o94SkJVpvpA2ZFqXvA04LaTFkDj7shOVbOWy2skHXXpIzHd7AxV-fk_eH-7J4itYvj8_FzTpSjAuIBGSxUDEXqNMM6kyLtBYNSs11olSepgnkjZJcgwCQTOWrjNXJSqimQcyVFnOSHHKVHZ2zqKvJmj4cWTGo9lKrbqqOUqtfqdVeagCXB3Da1T02_9hRofgBStp35Q</recordid><startdate>20170601</startdate><enddate>20170601</enddate><creator>Al Mahtab, Mamun</creator><creator>Mn Alam, Sheikh</creator><creator>L Moben, Ahmed</creator><creator>Raihan, Ruksana</creator><creator>A Alam, Mohammad</creator><creator>A Rahim, Mohammad</creator><creator>H Uddin, Mohammad</creator><creator>Fazle Akbar, Sheikh Mohammad</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20170601</creationdate><title>Therapy Targeting Stem Cell in Patients with Decompensated Cirrhosis of Liver in a Tertiary Treatment Care Center of Bangladesh</title><author>Al Mahtab, Mamun ; Mn Alam, Sheikh ; L Moben, Ahmed ; Raihan, Ruksana ; A Alam, Mohammad ; A Rahim, Mohammad ; H Uddin, Mohammad ; Fazle Akbar, Sheikh Mohammad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1230-30853c523ef780b8f37b3deaf2f6cc977609dca2f0300a1c9481b643cddee9cf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Al Mahtab, Mamun</creatorcontrib><creatorcontrib>Mn Alam, Sheikh</creatorcontrib><creatorcontrib>L Moben, Ahmed</creatorcontrib><creatorcontrib>Raihan, Ruksana</creatorcontrib><creatorcontrib>A Alam, Mohammad</creatorcontrib><creatorcontrib>A Rahim, Mohammad</creatorcontrib><creatorcontrib>H Uddin, Mohammad</creatorcontrib><creatorcontrib>Fazle Akbar, Sheikh Mohammad</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Euroasian journal of hepato-gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Al Mahtab, Mamun</au><au>Mn Alam, Sheikh</au><au>L Moben, Ahmed</au><au>Raihan, Ruksana</au><au>A Alam, Mohammad</au><au>A Rahim, Mohammad</au><au>H Uddin, Mohammad</au><au>Fazle Akbar, Sheikh Mohammad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapy Targeting Stem Cell in Patients with Decompensated Cirrhosis of Liver in a Tertiary Treatment Care Center of Bangladesh</atitle><jtitle>Euroasian journal of hepato-gastroenterology</jtitle><addtitle>Euroasian J Hepatogastroenterol</addtitle><date>2017-06-01</date><risdate>2017</risdate><volume>7</volume><issue>1</issue><spage>113</spage><epage>115</epage><pages>113-115</pages><issn>2231-5047</issn><eissn>2231-5128</eissn><abstract>Decompensated cirrhosis is associated with significantly high mortality resulting from hepatic failure, and liver transplantation seems to be the only viable indication for its management. The objective of this study is to assess if granulocyte colony-stimulating factor (G-CSF), a stimulatory of stem cell may be of any benefit for patients with decompensated cirrhosis of liver. Seventeen consecutive patients with decompensated cirrhosis of liver were recruited in this prospective study. They received injection of G-CSF (30 IU) over a period of 6 weeks (12 injections) in addition to standard of care. Patients were followed up at the end of treatment and at 12 weeks of treatment. Treatment was well tolerated, and no significant adverse event was recorded in any patient. Fifteen out of 17 (88%) patients were alive at last follow-up. Although serum bilirubin, albumin, and prothrombin time improved in some patients, statistically significant improvement of Child-Pugh score could not be documented. The study establishes the safety of G-CSF therapy in patients with decompensated cirrhosis of liver. Besides, such therapy may also have survival benefit, although long-term follow-up is needed to assess its real utility in clinical perspectives. Al Mahtab M, Alam SMN, Moben AL, Raihan R, Alam MA, Rahim MA, Uddin MH, Akbar SMF. Therapy Targeting Stem Cell in Patients with Decompensated Cirrhosis of Liver in a Tertiary Treatment Care Center of Bangladesh. Euroasian J Hepato-Gastroenterol 2017;7(1):113-115.</abstract><cop>India</cop><pmid>29201790</pmid><doi>10.5005/jp-journals-10018-1229</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2231-5047
ispartof Euroasian journal of hepato-gastroenterology, 2017-06, Vol.7 (1), p.113-115
issn 2231-5047
2231-5128
language eng
recordid cdi_crossref_primary_10_5005_jp_journals_10018_1229
source PubMed Central
title Therapy Targeting Stem Cell in Patients with Decompensated Cirrhosis of Liver in a Tertiary Treatment Care Center of Bangladesh
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T12%3A54%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapy%20Targeting%20Stem%20Cell%20in%20Patients%20with%20Decompensated%20Cirrhosis%20of%20Liver%20in%20a%20Tertiary%20Treatment%20Care%20Center%20of%20Bangladesh&rft.jtitle=Euroasian%20journal%20of%20hepato-gastroenterology&rft.au=Al%20Mahtab,%20Mamun&rft.date=2017-06-01&rft.volume=7&rft.issue=1&rft.spage=113&rft.epage=115&rft.pages=113-115&rft.issn=2231-5047&rft.eissn=2231-5128&rft_id=info:doi/10.5005/jp-journals-10018-1229&rft_dat=%3Cpubmed_cross%3E29201790%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1230-30853c523ef780b8f37b3deaf2f6cc977609dca2f0300a1c9481b643cddee9cf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/29201790&rfr_iscdi=true